SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury starts commercial production of high-potent anaesthetic API at Tanuku facility

28 Jan 2026 Evaluate

Wanbury has commenced commercial production for a high-potent anaesthetic API at its state-of-the-art facility in Tanuku, Andhra Pradesh. This positions the company to capture robust revenue growth for Q4FY26 and FY27. The new API is expected to generate incremental revenues of around Rs 18 crore in Q4 FY 2025-26.

Complementing this development, the company’s upcoming multi-purpose intermediate production block at Tanuku is on track for commercial readiness by the end of March 2026. This versatile facility will enable the production of four additional high-value APIs: Antidiabetic, Anticoagulant (Blood thinner), Cough suppressant (Anti Tussive), Antidepressant. Together, these four molecules are projected to deliver over Rs 100 crore in revenues for the company in FY 2026-27, fuelled by strong global demand. The worldwide market for these new APIs is currently valued at over Rs 5,000 crore, presenting substantial growth opportunities. 

Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.

Wanbury Share Price

260.35 1.30 (0.50%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×